Tear osmolarity in ocular graft-versus-host disease
L Berchicci, L Iuliano, E Miserocchi, F Bandello… - Cornea, 2014 - journals.lww.com
Purpose: The aim of this study was to evaluate tear osmolarity in patients with chronic graft-
versus-host disease (cGVHD) with ocular involvement. Methods: In this observational cross …
versus-host disease (cGVHD) with ocular involvement. Methods: In this observational cross …
Aberrant HLA-DR expression in the conjunctival epithelium after autologous serum treatment in patients with graft-versus-host disease or Sjögren's syndrome
K Jirsova, P Seidler Stangova, M Palos, G Mahelkova… - PloS one, 2020 - journals.plos.org
The aim of this study was to determine the effect of autologous serum (AS) eye drops on the
density of human leucocyte antigen (HLA)-DR-positive epithelial cells and Langerhans cells …
density of human leucocyte antigen (HLA)-DR-positive epithelial cells and Langerhans cells …
Patient-reported outcomes of autologous serum tears for the treatment of dry eye disease in a large cohort
M Kreimei, N Sorkin, T Boutin, AR Slomovic… - The Ocular Surface, 2019 - Elsevier
Purpose To assess patient satisfaction with autologous serum tears (AST) for the treatment
of dry eye disease (DED). Methods A prospective, observational case-series, including 100 …
of dry eye disease (DED). Methods A prospective, observational case-series, including 100 …
Insulin eye drops for severe refractory chronic ocular graft-versus-host disease
V Tahmaz, L Menghesha, ME Stern, U Holtick… - Bone Marrow …, 2024 - nature.com
Ocular graft-versus-host disease (oGVHD) is a common and severe complication after
allogeneic stem cell transplantation (aSCT) and affects up to 60% of patients who undergo …
allogeneic stem cell transplantation (aSCT) and affects up to 60% of patients who undergo …
Allogeneic serum eye drops for the treatment of persistent corneal epithelial defect
CC Chiang, WL Chen, JM Lin, YY Tsai - Eye, 2009 - nature.com
Purpose To evaluate the efficacy and safety of allogeneic serum in the treatment of
persistent corneal epithelial defect (PED). Methods Thirty-six patients with PED whose …
persistent corneal epithelial defect (PED). Methods Thirty-six patients with PED whose …
Dry eye disease is already present in hematological patients before hematopoietic stem cell transplantation
G Giannaccare, F Bonifazi, M Sessa, M Fresina… - Cornea, 2016 - journals.lww.com
Purpose: To analyze ocular surface parameters in patients before hematopoietic stem cell
transplantation (HSCT) and to correlate them with hematological characteristics. Methods …
transplantation (HSCT) and to correlate them with hematological characteristics. Methods …
Manifestation of Clinical Categories of Ocular Graft‐versus‐Host Disease
Y Qiu, J Hong, R Peng - Journal of Ophthalmology, 2018 - Wiley Online Library
This study aims at improving the understanding of the subjective symptoms and signs of two
different clinical categories of ocular graft‐versus‐host disease. After reviewing and …
different clinical categories of ocular graft‐versus‐host disease. After reviewing and …
Semifluorinated alkane eye drops in chronic ocular graft-versus-host disease: a prospective, multicenter, noninterventional study
P Eberwein, S Krösser, P Steven - Ophthalmic Research, 2020 - karger.com
Purpose: Ocular graft-versus-host disease (oGvHD) following allogeneic hematopoietic stem
cell transplantation develops as severe dry eye disease (DED) and is initially treated with …
cell transplantation develops as severe dry eye disease (DED) and is initially treated with …
Donor–recipient gender difference affects severity of dry eye after hematopoietic stem cell transplantation
M Kamoi, Y Ogawa, M Uchino, Y Tatematsu, T Mori… - Eye, 2011 - nature.com
Purpose To determine whether the incidence rate and severity of dry eye after hematopoietic
stem cell transplantation varies with donor vsrecipient gender. Methods We limited this study …
stem cell transplantation varies with donor vsrecipient gender. Methods We limited this study …
Evaluation of the efficacy of 50% autologous serum eye drops in different ocular surface pathologies
F Semeraro, E Forbice, O Braga, A Bova… - BioMed research …, 2014 - Wiley Online Library
Purpose. This study evaluated the efficacy of 50% autologous serum eye drops in ocular
surface diseases not improved by conventional therapy. Methods. We analyzed two …
surface diseases not improved by conventional therapy. Methods. We analyzed two …